Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers: European Journal of Preventive Cardiology

G. Cattadori, S. Di Marco, S. Farina, G. Limongelli, E. Monda, R. Badagliacca, S. Papa, L. Tricarico, M. Correale

Research output: Contribution to journalArticlepeer-review

Abstract

Heart failure is a complex syndrome affecting several organs including kidney, lungs, liver, brain muscles and sympathetic system. Each of these organs might contribute to its severity and prognosis. The prognosis assessment is critical for a correct heart failure management. It has already been demonstrated that a single parameter is weaker for prognosis than different parameters combined. The Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score has been built and validated for heart failure with reduced ejection fraction (HFrEF) patients by considering cardiopulmonary exercise test data combined with clinical, laboratory and echocardiographic measurements. The betablockers treatment is a milestone in the HFrEF management. In the MECKI score database, the association of betablockers treatment with outcome has been investigated in different settings. © The European Society of Cardiology 2020.
Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalEur. J. Prev. Cardiol.
Volume27
Issue number2_suppl
DOIs
Publication statusPublished - 2020

Keywords

  • heart failure
  • prognosis
  • β-blockers
  • beta adrenergic receptor blocking agent
  • bisoprolol
  • carvedilol
  • biological marker
  • anemia
  • Article
  • atrial fibrillation
  • cardiopulmonary exercise test
  • cardiopulmonary hemodynamics
  • chronic kidney failure
  • chronic obstructive lung disease
  • Heart Failure Survival Score
  • heart failure with preserved ejection fraction
  • heart failure with reduced ejection fraction
  • heart rate
  • heart transplantation
  • human
  • Metabolic Exercise test data combined with Cardiac and Kidney Indexes
  • oxygen consumption
  • priority journal
  • questionnaire
  • blood
  • cardiorespiratory fitness
  • convalescence
  • decision support system
  • echocardiography
  • exercise test
  • exercise tolerance
  • factual database
  • pathophysiology
  • predictive value
  • reproducibility
  • treatment outcome
  • Adrenergic beta-Antagonists
  • Biomarkers
  • Cardiorespiratory Fitness
  • Databases, Factual
  • Decision Support Techniques
  • Echocardiography
  • Exercise Test
  • Exercise Tolerance
  • Heart Failure
  • Humans
  • Oxygen Consumption
  • Predictive Value of Tests
  • Recovery of Function
  • Reproducibility of Results
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers: European Journal of Preventive Cardiology'. Together they form a unique fingerprint.

Cite this